Investing in Biotech: Cramer’s Take on a Particular Stock
WHAT YOU SHOULD KNOW
- Jim Cramer recently suggested holding shares of Biomarin Pharmaceutical Inc (BMRN).
- He also expressed his approval of Black Stone Minerals LP.
Jim Cramer, host of CNBC’s “Mad Money Lightning Round,” suggested that investors should hold shares of Biomarin Pharmaceutical Inc (BMRN). He expressed his approval of Black Stone Minerals LP BSM when asked.
Jim Cramer recently commented on Kura Oncology Inc when asked about personalized oncology companies. He said that some of them are likely to be successful, while others may not be.
BioMarin Pharmaceutical saw its stock price dip 0.1% on Wednesday, closing at $111.15, while Black Stone Minerals experienced a 1.5% decrease, settling at $15.71.
Kura Oncology experienced a 4.4% increase in its stock price, closing at $12.47 at the end of the day.
Investing Salary provides free access to quality, truthful news for everyone, believing that information should be equally accessible. We hope that this will enable more people to stay informed about current events, understand their effects, and be motivated to take action.
If you feel that we have helped you get the right market knowledge please consider supporting us through Patreon. Even a single dollar counts.